Financhill
Sell
29

ZVSA Quote, Financials, Valuation and Earnings

Last price:
$0.69
Seasonality move :
-30.48%
Day range:
$0.63 - $0.67
52-week range:
$0.47 - $6.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.38x
Volume:
226.3K
Avg. volume:
1.3M
1-year change:
-81.98%
Market cap:
$3.1M
Revenue:
--
EPS (TTM):
-$36.83

Earnings Data

Next earnings date for ZVSA
--
Most recent earnings per share
-$0.73
Missed by $0.73
(Mar 31/2025)
Consensus Estimate
--
(Mar 31/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ZVSA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 -- -- -$0.73 -- --
12/31/2024 Q4 -- -- -$0.57 -- --
09/30/2024 Q3 -- -- -$2.43 -$1.60 -$0.83
06/30/2024 Q2 -- -- -$33.10 -$3.75 -$29.35
03/31/2024 Q1 -- -- -$4.53 -$3.70 -$0.83
12/31/2023 Q4 -- -- -$32.92 -$21.40 -$11.52
09/30/2023 Q3 -- -- -$30.18 -$56.00 $25.82
06/30/2023 Q2 -- -- -$1,694.12 -- --
03/31/2023 Q1 -- -- -$1,358.80 -- --
12/31/2022 Q4 -- -- -$177.37 -- --
09/30/2022 Q3 -- -- -$515.54 -- --
06/30/2022 Q2 -- -- -$35.00 -- --
03/31/2022 Q1 -- -- -$54.17 -- --
12/31/2021 Q4 -- -- -$28.45 -- --
09/30/2021 Q3 -- -- -$27.16 -- --

ZyVersa Therapeutics Earnings Questions

  • How Much did ZyVersa Therapeutics Generate in Revenue Last Quarter?

    ZyVersa Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did ZyVersa Therapeutics Beat Earnings Last Quarter?

    ZyVersa Therapeutics announced earnings per share of -$0.73 which represents a miss of analyst forecast a -- per share.

  • Is ZyVersa Therapeutics Profitable?

    ZyVersa Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for ZyVersa Therapeutics EPS Next Year?

    ZyVersa Therapeutics's earnings are forecast to decrease from -$8.48 per share to -$12.43 per share next year representing a decrease of -98.86%.

  • When is ZyVersa Therapeutics's Earnings Date?

    Currently, ZyVersa Therapeutics has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on October 2, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Hershey Stock Be In 1 Year?
Where Will Hershey Stock Be In 1 Year?

Chocolate stocks used to be the epitome of sleepy stability,…

Where Will KNOT Stock Be In 1 Year?
Where Will KNOT Stock Be In 1 Year?

In the case of KNOT Offshore Partners (KNOP), most headlines…

Why Is Goldman Sachs Stock Up So Much?
Why Is Goldman Sachs Stock Up So Much?

Investment banking giant Goldman Sachs (NYSE:GS) has sharply outperformed the…

Stock Ideas

Buy
60
Is NVDA Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 52x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 42x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Alerts

Buy
60
AEVA alert for Jul 2

Aeva Technologies [AEVA] is up 7.78% over the past day.

Sell
44
PRGS alert for Jul 2

Progress Software [PRGS] is down 2.94% over the past day.

Sell
46
NAIL alert for Jul 2

Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 3.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock